Immunocore Holdings (IMCR) Long-Term Deferred Tax (2019 - 2025)

Immunocore Holdings (IMCR) has reported Long-Term Deferred Tax for 7 consecutive years, with $14.3 million the latest figure, recorded in Q3 2025.

• Quarterly Long-Term Deferred Tax rose 13.19% year-over-year to $14.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $14.3 million (up 13.19% YoY) and the FY2024 annual result came in at $14.8 million, up 34.79% from the prior year.
• Long-Term Deferred Tax rose to $14.3 million in Q3 2025 per IMCR's latest filing, from $14.1 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for IMCR reached as high as $14.8 million in Q4 2024 and fell as low as $3.5 million in Q4 2021.
• A 5-year average of $10.1 million and a median of $10.9 million in 2023 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2023 — Long-Term Deferred Tax soared 120.64% — and 2025, when it grew 13.19%.
• Year by year, Long-Term Deferred Tax stood at $3.5 million in 2021, then surged by 43.27% to $5.0 million in 2022, then surged by 120.64% to $11.0 million in 2023, then soared by 34.79% to $14.8 million in 2024, then slipped by 3.09% to $14.3 million in 2025.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $14.3 million, $14.1 million, and $14.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.